(S (NP (DT The) (NML (NML (NNP Coronavirus) (NNP Disease)) (-LRB- -LRB-) (NML (NNP COVID) (HYPH -) (CD 19)) (-RRB- -RRB-))) (VP (VP (VBZ has) (VP (VBN affected) (NP (QP (CD 1.8) (CD million)) (NNS people)))) (CC and) (VP (VBD resulted) (PP (IN in) (NP (QP (JJR more) (IN than) (CD 110,000)) (NNS deaths))) (PP (IN as) (PP (IN of) (NP (NNP April) (CD 12) (, ,) (CD 2020)))))) (. .))
(S (NP (JJ Several) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NP (JJ tomographic) (NNS patterns)) (VP (VBN seen) (PP (IN on) (NP (NP (NN chest)) (VP (VBN Computed) (NP (NN Tomography))))) (PRN (-LRB- -LRB-) (NP (NN CT)) (-RRB- -RRB-)))) (, ,) (PP (JJ such) (IN as) (NP (NP (NML (NN ground) (HYPH -) (NN glass)) (NNS opacities)) (, ,) (NP (NNS consolidations)) (, ,) (CC and) (NP (JJ crazy) (VBG paving) (NN pattern)))) (, ,)) (VP (VBP are) (VP (VBN correlated) (PP (IN with) (NP (DT the) (NN disease) (NN severity) (CC and) (NN progression))))))))) (. .))
(S (NP (NN CT) (NN imaging)) (VP (MD can) (ADVP (RB thus)) (VP (VB emerge) (PP (IN as) (NP (NP (DT an) (JJ important) (NN modality)) (PP (IN for) (NP (NP (DT the) (NN management)) (PP (IN of) (NP (NML (NN COVID) (HYPH -) (CD 19)) (NNS patients))))))))) (. .))
(S (NP (ADJP (NP (NN AI)) (HYPH -) (VBN based)) (NNS solutions)) (VP (MD can) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VP (VB support) (NP (NN CT)) (PP (VBN based) (NP (JJ quantitative) (NN reporting)))) (CC and) (VP (VB make) (S (NP (NN reading)) (ADJP (JJ efficient) (CC and) (JJ reproducible)) (SBAR (IN if) (S (NP (NP (JJ quantitative) (NNS biomarkers)) (, ,) (PP (JJ such) (IN as) (NP (NP (DT the) (NN Percentage)) (PP (IN of) (NP (NN Opacity) (-LRB- -LRB-) (NN PO) (-RRB- -RRB-))))) (, ,)) (VP (MD can) (VP (VB be) (ADVP (RB automatically)) (VP (VBN computed)))))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (NN COVID) (HYPH -) (CD 19)) (VP (VBZ has) (VP (VBN posed) (NP (JJ unique) (NNS challenges)) (PP (IN to) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN AI))))) (, ,) (S (ADVP (RB specifically)) (VP (VBG concerning) (NP (NP (DT the) (NN availability)) (PP (IN of) (NP (JJ appropriate) (NN image) (NML (NNS data) (CC and) (NNS annotations))))) (PP (IN at) (NP (NN scale))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP propose) (S (VP (TO to) (VP (VB use) (NP (JJ synthetic) (NNS datasets)) (S (VP (TO to) (VP (VB augment) (NP (DT an) (VBG existing) (NML (NN COVID) (HYPH -) (CD 19)) (NN database) (S (VP (TO to) (VP (VB tackle) (NP (DT these) (NNS challenges))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP train) (NP (NP (DT a) (JJ Generative) (NNP Adversarial) (NNP Network)) (-LRB- -LRB-) (NP (NNP GAN)) (-RRB- -RRB-)) (PP (IN to) (NP (NN inpaint))) (NP-TMP (NP (ADJP (NP (NN COVID) (HYPH -) (CD 19)) (JJ related)) (JJ tomographic) (NNS patterns)) (PP (IN on) (NP (NP (NN chest) (NNS CTs)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN without) (NP (JJ infectious) (NNS diseases))))))))) (. .))
(S (ADVP (RB Additionally)) (, ,) (NP (PRP we)) (VP (VBP leverage) (S (NP (NP (NN location) (NNS priors)) (VP (VBN derived) (PP (IN from) (NP (NP (ADJP (RB manually) (VBN labeled)) (NN COVID) (HYPH -) (CD 19)) (NP (NN chest) (NNS CTs) (NNS patients)))))) (VP (TO to) (VP (VB generate) (NP (JJ appropriate) (NN abnormality) (NNS distributions)))))) (. .))
(S (NP (JJ Synthetic) (NNS data)) (VP (VBP are) (VP (VBN used) (S (VP (TO to) (VP (VB improve) (NP (NP (DT both) (NN lung) (NN segmentation) (CC and) (NN segmentation)) (PP (IN of) (NP (NML (NN COVID) (HYPH -) (CD 19)) (NNS patterns)))) (PP (IN by) (S (VP (VBG adding) (NP (NP (CD 20) (NN %)) (PP (IN of) (NP (JJ synthetic) (NNS data)))) (PP (IN to) (NP (NP (DT the) (JJ real) (NN COVID)) (HYPH -) (NP (CD 19) (NN training) (NNS data)))))))))))) (. .))
(S (NP (PRP We)) (VP (VBD collected) (NP (CD 2143) (NN chest) (NNS CTs)) (, ,) (S (VP (VBG containing) (NP (NP (CD 327) (ADJP (NP (NN COVID) (HYPH -) (CD 19)) (JJ positive)) (NNS cases)) (, ,) (VP (VBN acquired) (PP (IN from) (NP (NP (CD 12) (NNS sites)) (PP (IN across) (NP (CD 7) (NNS countries)))))))))) (. .))
(S (PP (IN By) (S (VP (VBG testing) (PP (IN on) (NP (CD 100) (UCP (ADJP (NP (NN COVID) (HYPH -) (CD 19)) (JJ positive)) (CC and) (NML (CD 100) (NN control))) (NNS cases)))))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (JJ synthetic) (NNS data)) (VP (MD can) (VP (VB help) (S (VP (VB improve) (NP (NP (DT both) (NN lung) (NN segmentation) (PRN (-LRB- -LRB-) (NP (CD +6.02) (NN %)) (NP (NN lesion) (NML (NN inclusion) (NN rate))) (-RRB- -RRB-))) (CC and) (NP (NN abnormality) (NN segmentation) (PRN (-LRB- -LRB-) (NP (NML (CD +2.78) (NN %)) (NN dice) (NN coefficient)) (-RRB- -RRB-)))))))))) (, ,) (S (VP (VBG leading) (PP (IN to) (NP (DT an) (ADJP (RB overall) (RBR more) (JJ accurate)) (NN PO) (NN computation))))) (PRN (-LRB- -LRB-) (NP (NML (NML (CD +2.82) (NN %)) (NNP Pearson)) (NN coefficient)) (-RRB- -RRB-))) (. .))
